About Sprout Pharmaceuticals
Sprout Pharmaceuticals is a Healthcare company based in Raleigh (United States) founded in 2011, and was acquired by Bausch Health in August 2015. Drugs for hypoactive sexual desire disorder in women are developed. Sprout Pharmaceuticals has raised $185.16 million across 10 funding rounds from investors including Bausch Health. The company has 31 employees. Sprout Pharmaceuticals offers products and services including Women's Health Products. Its focus areas include Life Sciences, Women Health, Drugs and Reproductive Diseases. Its legal entity is SPROUT PHARMACEUTICALS, INC. Its competitors include Rejoni, Gameto and Nora Therapeutics; 3 of its 3 listed competitors have raised funding.
Company details
Sprout Pharmaceuticals was founded in 2011 and is headquartered in Raleigh, United States. Operations focus on the pharmaceutical sector, particularly womens health. An FDA-approved, non-hormonal medication named ADDYI has been developed to address hypoactive sexual desire disorder in premenopausal women. The companys efforts center on drug development for this specific medical condition.
- Headquarters Raleigh, United States
- Employees 31
- Stage Acquired
- SectorsHealthcare
- Phone•••• ••••
- Website sproutpharmaceuticals.com
- Social LinkedIn
- Acquired by Bausch Health (Aug 2015)
- Legal Name Sprout Pharmaceuticals, Inc.
- Total Equity Funding$185.16M (USD)
in 10 rounds
- Latest Funding Round$10.56M (USD), Series D
Dec 2024
- Investors
- Employee Count31
- Acquired byBausch Health
(Aug 2015)
Products & Services of Sprout Pharmaceuticals
Sprout Pharmaceuticals offers a comprehensive portfolio of products and services, including Women's Health Products.
Innovative solutions for women's sexual health advancements
Funding Insights of Sprout Pharmaceuticals
Sprout Pharmaceuticals has successfully raised a total of $185.16M across 10 strategic funding rounds. The most recent funding activity was a Series D round of $10.56 million completed in December 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $185.16M
- Total Rounds 10
- Last Round Series D — $10.56M
- First Round $5M
(Mar 2012)
All 10 funding rounds of Sprout Pharmaceuticals with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2024 | $10.56M | Series D | – | – | – |
| Apr 2023 | $7.06M | Series D | – | – | – |
| Aug 2022 | $27.97M | Series D | – | – | – |
| May 2022 | $25.07M | Series D | – | – | – |
| Sep 2019 | $20M | Series C | – | – | – |
| Dec 2017 | $4.5M | Series C | – | – | – |
| Jun 2015 | $50M | Series C | – | – | – |
| Jul 2014 | $15M | Series B | – | – | – |
| Jul 2012 | $20M | Series B | – | – | – |
| Mar 2012 | $5M | Series A | – | – | – |
1 investors in total: 1 institutional.
Investors in Sprout Pharmaceuticals
Sprout Pharmaceuticals has secured backing from 1 investor. Prominent investors backing the company include Bausch Health.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Therapeutics for multiple diseases including dermatology and neurology are developed. | 1960 | bauschhealth.com | Laval, Canada |
Investor details for Sprout Pharmaceuticals
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Sprout Pharmaceuticals
18 people are tracked at Sprout Pharmaceuticals (10 in leadership, 8 in team); the tracked headcount is 31.
| Name | Role | Group |
|---|---|---|
Eli Cooke | VP, Market Development and Supply Chain Operations | Leadership |
Cindy Eckert | CEO | Leadership |
Justin Miller | Chief Digital Officer (CDO) | Leadership |
Kendall King | Director Of Digital Media | Leadership |
Matthew Petzold | Chief Financial Officer | Leadership |
Fred Pruden | VP Technical Operations - Sprout Pharmaceuticals | Leadership |
Margaret Henry | Vice President and Controller | Leadership |
Robert Dahl | Director | Leadership |
Tina Harrell | Director Of Sales| Women's Health | Leadership |
Kristin Dew | Director of Financial Planning and Analysis | Leadership |
chrissy newbauer | Operations Manager | Team |
Derral VanLoon | IT/Facilities Manager | Team |
Eleanor Sukman | Area Sales Manager | Team |
Julie Maas | Area Sales Manager | Team |
Katie McCann | Senior Area Sales Manager | Team |
Jennifer Paris | Brand Partnership Manager | Team |
Marie Bauer | Area Sales Manager | Team |
Carole Harris | Area Sales Manager | Team |
Complete people profiles for Sprout Pharmaceuticals
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Sprout Pharmaceuticals
4 dated milestones of Sprout Pharmaceuticals across 13 years, from founding to its latest funding, stage changes and deals.
- Founded Sprout Pharmaceuticals is founded.
- Funding First funding round of $5.0M.
- Exit Acquired by Bausch Health.
- Funding Latest funding round, Series D, of $10.6M.
Competitors of Sprout Pharmaceuticals
Sprout Pharmaceuticals has 3 listed competitors in our database, 3 of them funded. They include Rejoni, Gameto and Nora Therapeutics.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| rejoni.com | 2020 | Bedford, United States | $41.25M | Therapeutics for women's health conditions are developed using innovative hydrogels. | ||
| gametogen.com | 2020 | United States | $127M | Therapeutics for fertility and menopause treatments are developed. | ||
| noratherapeutics.com | 2007 | Palo Alto, United States | $37.81M | Therapeutics for IVF failure and recurrent pregnancy loss are developed. |
Detailed competitors of Sprout Pharmaceuticals
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Sprout Pharmaceuticals
The website of Sprout Pharmaceuticals (sproutpharmaceuticals.com) receives about 1.3K visits a month.
- Monthly visits1.3K
▲ 16.4% vs previous month
Websites whose visitors overlap most with Sprout Pharmaceuticals. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| salix.com | 100% | 15.6K | #1,433,848 | View details | |
| medpharm.com | 98% | 5.3K | #6,145,162 | View details | |
merzusa.com | merzusa.com | 94% | #2,673,211 | – | |
| maynepharma.com | 87% | 18.6K | #918,677 | View details | |
| synergbiopharma.com | 83% | 10.4K | #2,303,747 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 7 similar websites and full traffic analytics for Sprout Pharmaceuticals
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 7 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Women's Health & Fertility
3 companies that operate in the same segment as Sprout Pharmaceuticals (Women's Health & Fertility) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of cell-free DNA testing for oncology, women’s health, and organ health | 2004 | Redwood City, California, United States | USD 152.1 M | USD 2.31 B | 4,430 | |
Therapeutics for women's healthcare are developed and offered. | 1997 | Princeton, New Jersey, United States | USD 123.06 M | USD 19.59 M | ||
Provider of cell-free cancer liquid biopsy test | 2015 | San Francisco, California, United States | USD 388.62 M | 861 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Sprout Pharmaceuticals
Complete news archive for Sprout Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sprout Pharmaceuticals
Sprout Pharmaceuticals was founded in 2011 and raised its 1st funding round 1 year after it was founded.
Sprout Pharmaceuticals is headquartered in Raleigh, United States. It is registered at Raleigh, North Carolina, United States.
Sprout Pharmaceuticals is a funded company, having raised a total of $185.16M across 10 funding rounds to date. The company's 1st funding round was a Series A of $5M, raised on Mar 2012.
Sprout Pharmaceuticals has 31 employees.
Sprout Pharmaceuticals was founded in 2011 and is headquartered in Raleigh, United States. Operations focus on the pharmaceutical sector, particularly womens health. An FDA-approved, non-hormonal medication named ADDYI has been developed to address hypoactive sexual desire disorder in premenopausal women. The companys efforts center on drug development for this specific medical condition.
Sprout Pharmaceuticals's top competitors include Rejoni, Gameto and Nora Therapeutics.
Sprout Pharmaceuticals offers Women's Health Products.
Sprout Pharmaceuticals has 1 investor. Key investors include Bausch Health.
Sprout Pharmaceuticals operates through Sprout Pharmaceuticals, Inc..
Yes. Sprout Pharmaceuticals was acquired by Bausch Health in August 2015.